Bristol-Myers Squibb Company (ETR:BRM)
47.53
-0.34 (-0.71%)
Jan 12, 2026, 10:58 AM CET
Bristol-Myers Squibb Company Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€1,200,568
Profits / Employee
€150,940
Market Cap
97.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | 30,250 | 250 | 0.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Bristol-Myers Squibb Company News
- 4 days ago - Bristol-Myers Squibb (BMY) Upgraded to Buy with Raised Price Target | BMY Stock News - GuruFocus
- 9 days ago - Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture? - Benzinga
- 9 days ago - Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference - Wallstreet:Online
- 11 days ago - Looking Into Bristol-Myers Squibb Co's Recent Short Interest - Benzinga
- 11 days ago - Ex-Dividend Reminder: Encompass Health, Bristol Myers Squibb and Federal Realty Investment Trust - Nasdaq
- 11 days ago - Can BMY's Growth Portfolio Drive Top-Line Expansion in 2026? - Nasdaq
- 12 days ago - Is Bristol Myers Squibb a Buy, Sell, or Hold in 2026? - The Motley Fool
- 13 days ago - Biotech Stocks Facing FDA Decision In January 2026 - Nasdaq